COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,367 Articles (22,803 medRxiv, 8,564 bioRxiv)

Most recent first Previous |  Page 40: Articles 391-400  | Next

Dynamical survival analysis for epidemic modeling under partial observability: A case study of COVID-19 in Kenya
KAGUNDA, J. W., Gothard, A., Rempala, G., Choi, B.
10.1101/2025.09.30.25337023 — Posted: 2025-10-02
Quantifying SARS-CoV-2 Omicron variant spread and the impact of non-pharmaceutical interventions in Newfoundland and Labrador, Canada
Anokye, F., Li, M. W., Walker, S., Hurford, A.
10.1101/2025.09.26.25336738 — Posted: 2025-10-02
Leveraging Multimodal Large Language Models to Extract Mechanistic Insights from Biomedical Visuals: A Case Study on COVID-19 and Neurodegenerative Diseases
Popova, E., Jacobs, M., Hofmann-Apitius, M., Babaiha, N. S.
10.1101/2025.10.01.679928 — Posted: 2025-10-02
Memory B cell Development in Response to mRNA SARS-CoV-2 and Nanoparticle Immunization in Mice
Wiatr, m., wang, z., Canis, M., Gazumyan, A., hernandez, B., Santos, G. S., Shawraz, S., lee, S., Bieniasz, P. D., Hatziioannou, T., Muecksch, F., Nussenzweig, M. C.
10.1101/2025.10.01.679787 — Posted: 2025-10-02
Directed evolution of a stem-helix targeting antibody enables MERS-CoV cross-neutralization through enhanced binding affinity
Zhou, P., Yuan, M., Zhang, Y., Limbo, O., Song, G., Zhao, F., Liu, H., He, W.-t., Capozzola, T., Callaghan, S., Avillion, G., Li, X., Beutler, N., Yong, P., Anzanello, F., Rogers, T. F., Burton, D. R., Jardine, J. G., Wilson, I. A., Andrabi, R.
10.1101/2025.10.02.680065 — Posted: 2025-10-02
Glycans modulate the adsorption of RBD Glycoproteins on polarizable surfaces
Bosch, A., Menacho, W., Perez, R., V. Guzman, H. V.
10.1101/2025.09.30.679433 — Posted: 2025-10-01
Enhanced human antigen-specific B cell responses using in vitro 3D tonsil cultures containing stromal cells
Braham, M. V. J., de Gast, M., Babii, L., Kruijer, S., Bestebroer, T. M., Richard, M., Claireaux, M., van Ham, M. S., de Wit, J., van Els, C. A. C. M., ten Brinke, A., van Gils, M.
10.1101/2025.09.30.679470 — Posted: 2025-10-01
Crystallographic characterisation and development of bi-substrate inhibitors of coronavirus nsp14 methyltransferase
Georgiou, I., Robinson, C., O'Byrne, S., Matsuda, A., Grygier, P., Smith, C., O'Neill, S., Ahmad, S. A., Post, J. M., Groenewold, M. G., Urakova, N., Wanningen, P., Kresik, L., Plewka, J., Delpal, A., See, K., Eadsforth, T., Norval, S., Wierzbicka, K., Decroly, E., Saikatendu, K. S., Chang, E., Snijder, E. J., Pyrc, K., Czarna, A., Scott, D. E., Gilbert, I. H.
10.1101/2025.09.30.679521 — Posted: 2025-10-01
Rational Design of Multiclade Coronavirus Spike Immunodominant Domain Nanoparticles Elicit Broad Antibody Responses
Dzuvor, C. K. O., Moak, S., McManus, L. R., Thomas, A., Dzordzorme, A. E., Kim, T., Joseph, J., Foley, V., Gordon, I. J., Novik, L., Holman, L. A., Dropulic, L. K., McNamara, R. P., Corbett-Helaire, K. S.
10.1101/2025.10.01.679649 — Posted: 2025-10-01
Plasma nirmatrelvir and molnupiravir concentrations required for inhibition of SARS CoV-2 replication differ between rhesus macaques and humans
Avila-Ponce de Leon, U., Esmaeili, S., Owens, K., Schiffer, J. T.
10.1101/2025.09.25.678525 — Posted: 2025-10-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).